TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Biosimilars 1.2 Key Market Segments 1.2.1 Biosimilars Segment by Type 1.2.2 Biosimilars Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Biosimilars Market Overview 2.1 Global Market Overview 2.1.1 Global Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Biosimilars Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Biosimilars Market Competitive Landscape 3.1 Global Biosimilars Sales by Manufacturers (2017-2022) 3.2 Global Biosimilars Revenue Market Share by Manufacturers (2017-2022) 3.3 Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Biosimilars Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Biosimilars Sales Sites, Area Served, Product Type 3.6 Biosimilars Market Competitive Situation and Trends 3.6.1 Biosimilars Market Concentration Rate 3.6.2 Global 5 and 10 Largest Biosimilars Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Biosimilars Industry Chain Analysis 4.1 Biosimilars Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Biosimilars Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Biosimilars Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Biosimilars Sales Market Share by Type (2017-2022) 6.3 Global Biosimilars Market Size Market Share by Type (2017-2022) 6.4 Global Biosimilars Price by Type (2017-2022) 7 Biosimilars Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Biosimilars Market Sales by Application (2017-2022) 7.3 Global Biosimilars Market Size (M USD) by Application (2017-2022) 7.4 Global Biosimilars Sales Growth Rate by Application (2017-2022) 8 Biosimilars Market Segmentation by Region 8.1 Global Biosimilars Sales by Region 8.1.1 Global Biosimilars Sales by Region 8.1.2 Global Biosimilars Sales Market Share by Region 8.2 North America 8.2.1 North America Biosimilars Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Biosimilars Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Biosimilars Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Biosimilars Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Biosimilars Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Pfizer 9.1.1 Pfizer Biosimilars Basic Information 9.1.2 Pfizer Biosimilars Product Overview 9.1.3 Pfizer Biosimilars Product Market Performance 9.1.4 Pfizer Business Overview 9.1.5 Pfizer Biosimilars SWOT Analysis 9.1.6 Pfizer Recent Developments 9.2 Novartis 9.2.1 Novartis Biosimilars Basic Information 9.2.2 Novartis Biosimilars Product Overview 9.2.3 Novartis Biosimilars Product Market Performance 9.2.4 Novartis Business Overview 9.2.5 Novartis Biosimilars SWOT Analysis 9.2.6 Novartis Recent Developments 9.3 Biocon 9.3.1 Biocon Biosimilars Basic Information 9.3.2 Biocon Biosimilars Product Overview 9.3.3 Biocon Biosimilars Product Market Performance 9.3.4 Biocon Business Overview 9.3.5 Biocon Biosimilars SWOT Analysis 9.3.6 Biocon Recent Developments 9.4 Biogen 9.4.1 Biogen Biosimilars Basic Information 9.4.2 Biogen Biosimilars Product Overview 9.4.3 Biogen Biosimilars Product Market Performance 9.4.4 Biogen Business Overview 9.4.5 Biogen Biosimilars SWOT Analysis 9.4.6 Biogen Recent Developments 9.5 Fresenius Kabi AG 9.5.1 Fresenius Kabi AG Biosimilars Basic Information 9.5.2 Fresenius Kabi AG Biosimilars Product Overview 9.5.3 Fresenius Kabi AG Biosimilars Product Market Performance 9.5.4 Fresenius Kabi AG Business Overview 9.5.5 Fresenius Kabi AG Biosimilars SWOT Analysis 9.5.6 Fresenius Kabi AG Recent Developments 9.6 Boehringer Ingelheim 9.6.1 Boehringer Ingelheim Biosimilars Basic Information 9.6.2 Boehringer Ingelheim Biosimilars Product Overview 9.6.3 Boehringer Ingelheim Biosimilars Product Market Performance 9.6.4 Boehringer Ingelheim Business Overview 9.6.5 Boehringer Ingelheim Recent Developments 9.7 Merck KgaA 9.7.1 Merck KgaA Biosimilars Basic Information 9.7.2 Merck KgaA Biosimilars Product Overview 9.7.3 Merck KgaA Biosimilars Product Market Performance 9.7.4 Merck KgaA Business Overview 9.7.5 Merck KgaA Recent Developments 9.8 Mylan 9.8.1 Mylan Biosimilars Basic Information 9.8.2 Mylan Biosimilars Product Overview 9.8.3 Mylan Biosimilars Product Market Performance 9.8.4 Mylan Business Overview 9.8.5 Mylan Recent Developments 9.9 Eli Lilly 9.9.1 Eli Lilly Biosimilars Basic Information 9.9.2 Eli Lilly Biosimilars Product Overview 9.9.3 Eli Lilly Biosimilars Product Market Performance 9.9.4 Eli Lilly Business Overview 9.9.5 Eli Lilly Recent Developments 9.10 Teva Pharmaceutical 9.10.1 Teva Pharmaceutical Biosimilars Basic Information 9.10.2 Teva Pharmaceutical Biosimilars Product Overview 9.10.3 Teva Pharmaceutical Biosimilars Product Market Performance 9.10.4 Teva Pharmaceutical Business Overview 9.10.5 Teva Pharmaceutical Recent Developments 9.11 Dr. Reddy's Laboratories 9.11.1 Dr. Reddy's Laboratories Biosimilars Basic Information 9.11.2 Dr. Reddy's Laboratories Biosimilars Product Overview 9.11.3 Dr. Reddy's Laboratories Biosimilars Product Market Performance 9.11.4 Dr. Reddy's Laboratories Business Overview 9.11.5 Dr. Reddy's Laboratories Recent Developments 9.12 Amgen 9.12.1 Amgen Biosimilars Basic Information 9.12.2 Amgen Biosimilars Product Overview 9.12.3 Amgen Biosimilars Product Market Performance 9.12.4 Amgen Business Overview 9.12.5 Amgen Recent Developments 9.13 Celltrion 9.13.1 Celltrion Biosimilars Basic Information 9.13.2 Celltrion Biosimilars Product Overview 9.13.3 Celltrion Biosimilars Product Market Performance 9.13.4 Celltrion Business Overview 9.13.5 Celltrion Recent Developments 9.14 Samsung Biologics 9.14.1 Samsung Biologics Biosimilars Basic Information 9.14.2 Samsung Biologics Biosimilars Product Overview 9.14.3 Samsung Biologics Biosimilars Product Market Performance 9.14.4 Samsung Biologics Business Overview 9.14.5 Samsung Biologics Recent Developments 9.15 Roche 9.15.1 Roche Biosimilars Basic Information 9.15.2 Roche Biosimilars Product Overview 9.15.3 Roche Biosimilars Product Market Performance 9.15.4 Roche Business Overview 9.15.5 Roche Recent Developments 9.16 Probiomed 9.16.1 Probiomed Biosimilars Basic Information 9.16.2 Probiomed Biosimilars Product Overview 9.16.3 Probiomed Biosimilars Product Market Performance 9.16.4 Probiomed Business Overview 9.16.5 Probiomed Recent Developments 9.17 Apotex 9.17.1 Apotex Biosimilars Basic Information 9.17.2 Apotex Biosimilars Product Overview 9.17.3 Apotex Biosimilars Product Market Performance 9.17.4 Apotex Business Overview 9.17.5 Apotex Recent Developments 9.18 Chong Kun Dang 9.18.1 Chong Kun Dang Biosimilars Basic Information 9.18.2 Chong Kun Dang Biosimilars Product Overview 9.18.3 Chong Kun Dang Biosimilars Product Market Performance 9.18.4 Chong Kun Dang Business Overview 9.18.5 Chong Kun Dang Recent Developments 9.19 JCR Pharmaceuticals 9.19.1 JCR Pharmaceuticals Biosimilars Basic Information 9.19.2 JCR Pharmaceuticals Biosimilars Product Overview 9.19.3 JCR Pharmaceuticals Biosimilars Product Market Performance 9.19.4 JCR Pharmaceuticals Business Overview 9.19.5 JCR Pharmaceuticals Recent Developments 9.20 Gan and Lee Pharmaceuticals 9.20.1 Gan and Lee Pharmaceuticals Biosimilars Basic Information 9.20.2 Gan and Lee Pharmaceuticals Biosimilars Product Overview 9.20.3 Gan and Lee Pharmaceuticals Biosimilars Product Market Performance 9.20.4 Gan and Lee Pharmaceuticals Business Overview 9.20.5 Gan and Lee Pharmaceuticals Recent Developments 9.21 Gedeon Richter 9.21.1 Gedeon Richter Biosimilars Basic Information 9.21.2 Gedeon Richter Biosimilars Product Overview 9.21.3 Gedeon Richter Biosimilars Product Market Performance 9.21.4 Gedeon Richter Business Overview 9.21.5 Gedeon Richter Recent Developments 9.22 Biocad 9.22.1 Biocad Biosimilars Basic Information 9.22.2 Biocad Biosimilars Product Overview 9.22.3 Biocad Biosimilars Product Market Performance 9.22.4 Biocad Business Overview 9.22.5 Biocad Recent Developments 9.23 Coherus Bioscience 9.23.1 Coherus Bioscience Biosimilars Basic Information 9.23.2 Coherus Bioscience Biosimilars Product Overview 9.23.3 Coherus Bioscience Biosimilars Product Market Performance 9.23.4 Coherus Bioscience Business Overview 9.23.5 Coherus Bioscience Recent Developments 9.24 Stada Arzneimittel AG 9.24.1 Stada Arzneimittel AG Biosimilars Basic Information 9.24.2 Stada Arzneimittel AG Biosimilars Product Overview 9.24.3 Stada Arzneimittel AG Biosimilars Product Market Performance 9.24.4 Stada Arzneimittel AG Business Overview 9.24.5 Stada Arzneimittel AG Recent Developments 10 Biosimilars Market Forecast by Region 10.1 Global Biosimilars Market Size Forecast 10.2 Global Biosimilars Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Biosimilars Market Size Forecast by Country 10.2.3 Asia Pacific Biosimilars Market Size Forecast by Region 10.2.4 South America Biosimilars Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Biosimilars by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Biosimilars Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Biosimilars by Type (2022-2028) 11.1.2 Global Biosimilars Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Biosimilars by Type (2022-2028) 11.2 Global Biosimilars Market Forecast by Application (2022-2028) 11.2.1 Global Biosimilars Sales (K Units) Forecast by Application 11.2.2 Global Biosimilars Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Biosimilars Market Size (M USD) Comparison by Region (M USD) Table 5. Global Biosimilars Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Biosimilars Sales Market Share by Manufacturers (2017-2022) Table 7. Global Biosimilars Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Biosimilars Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars as of 2021) Table 10. Global Market Biosimilars Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Biosimilars Sales Sites and Area Served Table 12. Manufacturers Biosimilars Product Type Table 13. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Biosimilars Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Biosimilars Market Challenges Table 22. Market Restraints Table 23. Global Biosimilars Sales by Type (K Units) Table 24. Global Biosimilars Market Size by Type (M USD) Table 25. Global Biosimilars Sales (K Units) by Type (2017-2022) Table 26. Global Biosimilars Sales Market Share by Type (2017-2022) Table 27. Global Biosimilars Market Size (M USD) by Type (2017-2022) Table 28. Global Biosimilars Market Size Share by Type (2017-2022) Table 29. Global Biosimilars Price (USD/Unit) by Type (2017-2022) Table 30. Global Biosimilars Sales (K Units) by Application Table 31. Global Biosimilars Market Size by Application Table 32. Global Biosimilars Sales by Application (2017-2022) & (K Units) Table 33. Global Biosimilars Sales Market Share by Application (2017-2022) Table 34. Global Biosimilars Sales by Application (2017-2022) & (M USD) Table 35. Global Biosimilars Market Share by Application (2017-2022) Table 36. Global Biosimilars Sales Growth Rate by Application (2017-2022) Table 37. Global Biosimilars Sales by Region (2017-2022) & (K Units) Table 38. Global Biosimilars Sales Market Share by Region (2017-2022) Table 39. North America Biosimilars Sales by Country (2017-2022) & (K Units) Table 40. Europe Biosimilars Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Biosimilars Sales by Region (2017-2022) & (K Units) Table 42. South America Biosimilars Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Biosimilars Sales by Region (2017-2022) & (K Units) Table 44. Pfizer Biosimilars Basic Information Table 45. Pfizer Biosimilars Product Overview Table 46. Pfizer Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Pfizer Business Overview Table 48. Pfizer Biosimilars SWOT Analysis Table 49. Pfizer Recent Developments Table 50. Novartis Biosimilars Basic Information Table 51. Novartis Biosimilars Product Overview Table 52. Novartis Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Novartis Business Overview Table 54. Novartis Biosimilars SWOT Analysis Table 55. Novartis Recent Developments Table 56. Biocon Biosimilars Basic Information Table 57. Biocon Biosimilars Product Overview Table 58. Biocon Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Biocon Business Overview Table 60. Biocon Biosimilars SWOT Analysis Table 61. Biocon Recent Developments Table 62. Biogen Biosimilars Basic Information Table 63. Biogen Biosimilars Product Overview Table 64. Biogen Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Biogen Business Overview Table 66. Biogen Biosimilars SWOT Analysis Table 67. Biogen Recent Developments Table 68. Fresenius Kabi AG Biosimilars Basic Information Table 69. Fresenius Kabi AG Biosimilars Product Overview Table 70. Fresenius Kabi AG Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Fresenius Kabi AG Business Overview Table 72. Fresenius Kabi AG Biosimilars SWOT Analysis Table 73. Fresenius Kabi AG Recent Developments Table 74. Boehringer Ingelheim Biosimilars Basic Information Table 75. Boehringer Ingelheim Biosimilars Product Overview Table 76. Boehringer Ingelheim Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Recent Developments Table 79. Merck KgaA Biosimilars Basic Information Table 80. Merck KgaA Biosimilars Product Overview Table 81. Merck KgaA Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Merck KgaA Business Overview Table 83. Merck KgaA Recent Developments Table 84. Mylan Biosimilars Basic Information Table 85. Mylan Biosimilars Product Overview Table 86. Mylan Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Mylan Business Overview Table 88. Mylan Recent Developments Table 89. Eli Lilly Biosimilars Basic Information Table 90. Eli Lilly Biosimilars Product Overview Table 91. Eli Lilly Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Recent Developments Table 94. Teva Pharmaceutical Biosimilars Basic Information Table 95. Teva Pharmaceutical Biosimilars Product Overview Table 96. Teva Pharmaceutical Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Teva Pharmaceutical Business Overview Table 98. Teva Pharmaceutical Recent Developments Table 99. Dr. Reddy's Laboratories Biosimilars Basic Information Table 100. Dr. Reddy's Laboratories Biosimilars Product Overview Table 101. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Dr. Reddy's Laboratories Business Overview Table 103. Dr. Reddy's Laboratories Recent Developments Table 104. Amgen Biosimilars Basic Information Table 105. Amgen Biosimilars Product Overview Table 106. Amgen Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Amgen Business Overview Table 108. Amgen Recent Developments Table 109. Celltrion Biosimilars Basic Information Table 110. Celltrion Biosimilars Product Overview Table 111. Celltrion Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Celltrion Business Overview Table 113. Celltrion Recent Developments Table 114. Samsung Biologics Biosimilars Basic Information Table 115. Samsung Biologics Biosimilars Product Overview Table 116. Samsung Biologics Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Samsung Biologics Business Overview Table 118. Samsung Biologics Recent Developments Table 119. Roche Biosimilars Basic Information Table 120. Roche Biosimilars Product Overview Table 121. Roche Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Roche Business Overview Table 123. Roche Recent Developments Table 124. Probiomed Biosimilars Basic Information Table 125. Probiomed Biosimilars Product Overview Table 126. Probiomed Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Probiomed Business Overview Table 128. Probiomed Recent Developments Table 129. Apotex Biosimilars Basic Information Table 130. Apotex Biosimilars Product Overview Table 131. Apotex Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Apotex Business Overview Table 133. Apotex Recent Developments Table 134. Chong Kun Dang Biosimilars Basic Information Table 135. Chong Kun Dang Biosimilars Product Overview Table 136. Chong Kun Dang Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 137. Chong Kun Dang Business Overview Table 138. Chong Kun Dang Recent Developments Table 139. JCR Pharmaceuticals Biosimilars Basic Information Table 140. JCR Pharmaceuticals Biosimilars Product Overview Table 141. JCR Pharmaceuticals Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 142. JCR Pharmaceuticals Business Overview Table 143. JCR Pharmaceuticals Recent Developments Table 144. Gan and Lee Pharmaceuticals Biosimilars Basic Information Table 145. Gan and Lee Pharmaceuticals Biosimilars Product Overview Table 146. Gan and Lee Pharmaceuticals Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 147. Gan and Lee Pharmaceuticals Business Overview Table 148. Gan and Lee Pharmaceuticals Recent Developments Table 149. Gedeon Richter Biosimilars Basic Information Table 150. Gedeon Richter Biosimilars Product Overview Table 151. Gedeon Richter Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 152. Gedeon Richter Business Overview Table 153. Gedeon Richter Recent Developments Table 154. Biocad Biosimilars Basic Information Table 155. Biocad Biosimilars Product Overview Table 156. Biocad Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 157. Biocad Business Overview Table 158. Biocad Recent Developments Table 159. Coherus Bioscience Biosimilars Basic Information Table 160. Coherus Bioscience Biosimilars Product Overview Table 161. Coherus Bioscience Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 162. Coherus Bioscience Business Overview Table 163. Coherus Bioscience Recent Developments Table 164. Stada Arzneimittel AG Biosimilars Basic Information Table 165. Stada Arzneimittel AG Biosimilars Product Overview Table 166. Stada Arzneimittel AG Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 167. Stada Arzneimittel AG Business Overview Table 168. Stada Arzneimittel AG Recent Developments Table 169. Global Biosimilars Sales Forecast by Region (K Units) Table 170. Global Biosimilars Market Size Forecast by Region (M USD) Table 171. North America Biosimilars Sales Forecast by Country (2022-2028) & (K Units) Table 172. North America Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) Table 173. Europe Biosimilars Sales Forecast by Country (2022-2028) & (K Units) Table 174. Europe Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) Table 175. Asia Pacific Biosimilars Sales Forecast by Region (2022-2028) & (K Units) Table 176. Asia Pacific Biosimilars Market Size Forecast by Region (2022-2028) & (M USD) Table 177. South America Biosimilars Sales Forecast by Country (2022-2028) & (K Units) Table 178. South America Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) Table 179. Middle East and Africa Biosimilars Consumption Forecast by Country (2022-2028) & (Units) Table 180. Middle East and Africa Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) Table 181. Global Biosimilars Sales Forecast by Type (2022-2028) & (K Units) Table 182. Global Biosimilars Market Size Forecast by Type (2022-2028) & (M USD) Table 183. Global Biosimilars Price Forecast by Type (2022-2028) & (USD/Unit) Table 184. Global Biosimilars Sales (K Units) Forecast by Application (2022-2028) Table 185. Global Biosimilars Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Biosimilars Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Biosimilars Market Size (M USD), 2017-2028 Figure 5. Global Biosimilars Market Size (M USD) (2017-2028) Figure 6. Global Biosimilars Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Biosimilars Market Size (M USD) by Country (M USD) Figure 11. Biosimilars Sales Share by Manufacturers in 2020 Figure 12. Global Biosimilars Revenue Share by Manufacturers in 2020 Figure 13. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilars Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Biosimilars Market Share by Type Figure 18. Sales Market Share of Biosimilars by Type (2017-2022) Figure 19. Sales Market Share of Biosimilars by Type in 2021 Figure 20. Market Size Share of Biosimilars by Type (2017-2022) Figure 21. Market Size Market Share of Biosimilars by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Biosimilars Market Share by Application Figure 24. Global Biosimilars Sales Market Share by Application (2017-2022) Figure 25. Global Biosimilars Sales Market Share by Application in 2021 Figure 26. Global Biosimilars Market Share by Application (2017-2022) Figure 27. Global Biosimilars Market Share by Application in 2020 Figure 28. Global Biosimilars Sales Growth Rate by Application (2017-2022) Figure 29. Global Biosimilars Sales Market Share by Region (2017-2022) Figure 30. North America Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Biosimilars Sales Market Share by Country in 2020 Figure 32. U.S. Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Biosimilars Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Biosimilars Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Biosimilars Sales Market Share by Country in 2020 Figure 37. Germany Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Biosimilars Sales and Growth Rate (K Units) Figure 43. Asia Pacific Biosimilars Sales Market Share by Region in 2020 Figure 44. China Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Biosimilars Sales and Growth Rate (K Units) Figure 50. South America Biosimilars Sales Market Share by Country in 2020 Figure 51. Brazil Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Biosimilars Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Biosimilars Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Biosimilars Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Biosimilars Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Biosimilars Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Biosimilars Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Biosimilars Market Share Forecast by Type (2022-2028) Figure 65. Global Biosimilars Sales Forecast by Application (2022-2028) Figure 66. Global Biosimilars Market Share Forecast by Application (2022-2028)

•Pfizer •Novartis •Biocon •Biogen •Fresenius Kabi AG •Boehringer Ingelheim •Merck KgaA •Mylan •Eli Lilly •Teva Pharmaceutical •Dr. Reddy's Laboratories •Amgen •Celltrion •Samsung Biologics •Roche •Probiomed •Apotex •Chong Kun Dang •JCR Pharmaceuticals •Gan and Lee Pharmaceuticals •Gedeon Richter •Biocad •Coherus Bioscience •Stada Arzneimittel AG